Skip to main content
BioInvent International logo

BioInvent International — Investor Relations & Filings

Ticker · BINV ISIN · SE0015244520 LEI · 549300E7QRHEF2IJUY10 ST Manufacturing
Open in API
Filings indexed 679 across all filing types
Latest filing 2019-06-28 Declaration of Voting R…
Country SE Sweden
Listing ST BINV

About BioInvent International

https://www.bioinvent.com/en

BioInvent International is a clinical-stage company that discovers and develops novel, first-in-class immuno-modulatory antibodies for cancer therapy. Leveraging extensive expertise in immunology, cancer biology, and antibody biology, the company generates innovative immuno-oncology drug candidates for its clinical pipeline. BioInvent's operations include an in-house manufacturing facility to produce antibodies for its preclinical studies and clinical trials, with the goal of developing treatments that can transform the lives of cancer patients.

Recent filings

Filing Released Lang Actions
Change in the number of shares and votes in BioInvent International AB
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document explicitly announces a 'Change in the number of shares and votes in BioInvent International AB'. It details that the total number of shares increased due to the payment of shares under a Board Share Programme and the exercise of warrants, resulting in an increase of 669,936 shares. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). It is not a general financing announcement (CAP), nor a transaction in own shares (POS), as it is specifically detailing the result of a warrant exercise/share program leading to a change in the total outstanding share count.
2019-06-28 English
Ändring av antalet aktier och röster i BioInvent International AB
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a short announcement dated June 28, 2019, titled "Ändring av antalet aktier och röster i BioInvent International AB" (Change in the number of shares and votes in BioInvent International AB). It explicitly states that the total number of shares has changed due to the payout of shares under a board share program and the exercise of warrants. This directly relates to a change in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA), which covers changes in the number of shares. It is not a general earnings release (ER), a dividend notice (DIV), or a director's dealing (DIRS). Given the specific nature of the change in the total share count, SHA is the most appropriate classification.
2019-06-28 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly report ('delårsrapport') for BioInvent covering the period 1 January to 31 March 2019. It contains detailed financial data (net sales, profit/loss, cash flow), business highlights, and operational updates. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q1 2019
2019-05-22 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Classification · 100% confidence The document is titled 'BioInvent Interim Report January 1 – March 31, 2019'. It contains detailed financial data, including net sales, earnings, liquid funds, and cash flow, as well as a comprehensive review of business operations, pipeline status, and management commentary. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-22 English
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for a specific instrument (Aktier) by a holder (Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension). It explicitly mentions 'Reason for major shareholding notification' and provides 'Before the transaction' and 'After the transaction' figures, including the resulting percentage (5.64% directly held shares). This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the code MRQ.
2019-05-03 English
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage by a specific holder (Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension) involving a specific number of shares and the resulting voting rights percentage. It includes fields like 'Before the transaction', 'After the transaction', 'Percentage', and 'Reason for major shareholding notification'. This structure is characteristic of a notification regarding a significant change in ownership, which aligns directly with the definition of Major Shareholding Notification (MRQ). The document is not a full annual report (10-K), an earnings release (ER), or a director's dealing (DIRS), but specifically tracks ownership thresholds.
2019-05-02 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.